CHEMILUMINESCENCE IMMUNOASSAY MARKET ANALYSIS

Key Developments

• In November 2023, Medical & Biological Laboratories Co., Ltd., a JSR Life Sciences Company, launched the "iStar 500," an automated mono-test chemiluminescence immunoassay (CLIA) analyzer worldwide. This compact and highly sensitive analyzer is ideal for emergency and small- to medium-sized labs, offering a wide range of testing parameters including cardiac markers, reproductive health, liver health, tumor markers, and autoimmunity.
• In July 2023, Fapon, a prominent global life sciences company, unveiled its newest chemiluminescence immunoassay system, the Shine i8000/9000, at the 2023 AACC exhibition. This advanced analyzer is fully automated and operates at high speed, boasting an ultra-high throughput of 900 tests per hour. It is designed to enable Fapon's partners to develop top-tier clinical diagnostic solutions.
• In May 2023, PerkinElmer, a global provider of technology and service solutions, introduced Revvity, a pioneering science-driven solutions company that leverages advanced innovation to improve lives through a diverse array of products
• In December 2022, Sysmex obtained approval in Japan for manufacturing and marketing the HISCL β-Amyloid 1-42 Assay Kit and the HISCL β-Amyloid 1-40 Assay Kit, designed to detect levels of amyloid beta (Aβ) in blood
• In June 2020, Abbott, a global healthcare company, initiated supply of its laboratory-based serology blood test for detecting COVID-19 antibodies (IgG) in India. The company is delivering millions of tests to hospitals and labs across Maharashtra, Delhi, West Bengal, Uttar Pradesh, Jammu & Kashmir, and Gujarat, both government and private.